New treatment could tackle preventable causes of death for newborns in sub-Saharan Africa

May 15, 2012

Clinical trials are urgently needed to test a new treatment that could jointly tackle leading causes of death for babies in sub-Saharan Africa, according to researchers from the London School of Hygiene & Tropical Medicine.

A study published in the Journal of the American Medical Association today suggests that a considerable number of accessing antenatal care in the region have and sexually transmitted/reproductive tract infections (STIs/RTIs).

An estimated 25 million pregnancies are at risk of malaria each year in . The study shows that nearly 4 of every 10 women at health facilities have a malaria infection. An even higher number of women, if added together, are infected with the STIs/RTIs syphilis, gonorrhoea, chlamydia, trichomononiasis and bacterial vaginosis.

There are 880,000 stillbirths and 1.2 million newborn deaths each year in sub-Saharan Africa, many of which are linked to maternal infection. For unborn , malaria and STIs/RTIs increase the risk of miscarriage, stillbirth, and preterm delivery; they also contribute to low birth-weight, the leading cause of neonatal mortality.

Researchers from the London School of Hygiene & Tropical Medicine are now conducting of combined anti-malarial and antibiotic treatment that could prevent and treat malaria and STIs/RTIs at the same time.

Lead author Matthew Chico, an epidemiologist and Research Fellow at the London School of Hygiene & Tropical Medicine, said: "We reviewed evidence over a twenty year period to calculate prevalence estimates of STIs/RTIs and malaria. This makes it clear that a combined treatment could save a great many lives.

"We are now conducting trials of azithromycin-based combination treatment to give all pregnant women preventative medication that will clear placental malaria infection, protect against re-infection in between antenatal visits, and cure syphilis, gonorrhoea, chlamydia and, to a lesser extent, trichomononiasis, the most common STI in the world. If given in early pregnancy, combined treatment may also reduce bacterial vaginosis, which affects half of all pregnant women in the region."

The researchers also hope that combined treatment could overcome the problem of wide-spread anti-malarial drug resistance with the current treatment given to pregnant women.

"The current WHO recommended treatment to prevent malaria in pregnancy is failing due to drug resistance," Matthew Chico said. "By switching to azithromycin-based combination to reduce the dual burden of malaria and STIs/RTIs in pregnancy, we could have a transformative effect on maternal, fetal and neonatal health."

Explore further: Malaria during pregnancy: New study assesses risks during first trimester

Related Stories

Malaria during pregnancy: New study assesses risks during first trimester

December 13, 2011
The largest ever study to assess the effects of malaria and its treatment in the first trimester of pregnancy has shown that the disease significantly increases the risk of miscarriage, but that treating with antimalarial ...

Ultrasound study provides first direct evidence of effect of malaria on fetal growth

February 9, 2012
A study of almost 3,800 pregnancies has provided the most accurate and direct evidence to date that malaria infection reduces early foetal growth. Low birth weight is the most important risk factor for neonatal mortality ...

Malaria immunity in the spotlight

February 23, 2012
(Medical Xpress) -- Mothers who are treated for malaria may pass on lower levels of natural immunity to their young, animal studies show.

Recommended for you

Novel approach to track HIV infection

August 18, 2017
Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions—infectious particles—to be connected to infectivity.

Faulty gene linked to obesity in adults

August 18, 2017
Groundbreaking new research linking obesity and metabolic dysfunction to a problem in the energy generators in cells has been published by researchers from the Harry Perkins Institute of Medical Research and The University ...

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

Addressing superbug resistance with phage therapy

August 16, 2017
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

Can previous exposure to west Nile alter the course of Zika?

August 15, 2017
West Nile virus is no stranger to the U.S.-Mexico border; thousands of people in the region have contracted the mosquito-borne virus in the past. But could this previous exposure affect how intensely Zika sickens someone ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.